Literature DB >> 24637578

Anticancer properties of Monascus metabolites.

Tao Yang1, Junwen Liu, Feijun Luo, Qinlu Lin, Thomas J Rosol, Xiyun Deng.   

Abstract

This review provides up-to-date information on the anticancer properties of Monascus-fermented products. Topics covered include clinical evidence for the anticancer potential of Monascus metabolites, bioactive Monascus components with anticancer potential, mechanisms of the anticancer effects of Monascus metabolites, and existing problems as well as future perspectives. With the advancement of related fields, the development of novel anticancer Monascus food products and/or pharmaceuticals will be possible with the ultimate goal of decreasing the incidence and mortality of malignancies in humans.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24637578     DOI： 10.1097/CAD.0000000000000102

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN： 0959-4973            Impact factor:   2.248


  8 in total

1.  Lovastatin Inhibits Cancer Stem Cells and Sensitizes to Chemo- and Photodynamic Therapy in Nasopharyngeal Carcinoma.

Authors:  Yikun Peng; Guangchun He; Da Tang; Li Xiong; Yu Wen; Xiongying Miao; Zhangyong Hong; Hui Yao; Chao Chen; Shichao Yan; Lu Lu; Yingke Yang; Qinglong Li; Xiyun Deng
Journal:  J Cancer       Date:  2017-06-03       Impact factor: 4.207

Review 2.  Triple-negative breast cancer: is there a treatment on the horizon?

Authors:  Hui Yao; Guangchun He; Shichao Yan; Chao Chen; Liujiang Song; Thomas J Rosol; Xiyun Deng
Journal:  Oncotarget       Date:  2017-01-03

3.  Nucleolar stress: is there a reverse version?

Authors:  Lu Lu; Huimei Yi; Chao Chen; Shichao Yan; Hui Yao; Guangchun He; Guifei Li; Yiqun Jiang; Tuo Deng; Xiyun Deng
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

4.  Reversal of HER2 Negativity: An Unexpected Role for Lovastatin in Triple-Negative Breast Cancer Stem Cells.

Authors:  Huimei Yi; Mi Wu; Qiuting Zhang; Lu Lu; Hui Yao; Sisi Chen; Ying Li; Chanjuan Zheng; Guangchun He; Xiyun Deng
Journal:  J Cancer       Date:  2020-03-31       Impact factor: 4.207

5.  Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells.

Authors:  Lian Xue; Mi Wu; Ying Li; Sisi Chen; Muyao Wu; Jianyu Zhu; Siyu Ding; Qiuting Zhang; Chanjuan Zheng; Guangchun He; Shujun Fu; Guifei Li; Xiyun Deng
Journal:  J Cancer       Date:  2022-09-21       Impact factor: 4.478

6.  Effects of Lovastatin on MDA-MB-231 Breast Cancer Cells: An Antibody Microarray Analysis.

Authors:  Tao Yang; Hui Yao; Guangchun He; Liujiang Song; Ning Liu; Yan Wang; Yingke Yang; Evan T Keller; Xiyun Deng
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

Review 7.  Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer.

Authors:  Puvanesswaray Ramakrishnan; Wei Mee Loh; Subash C B Gopinath; Srinivasa Reddy Bonam; Ismail M Fareez; Rhanye Mac Guad; Maw Shin Sim; Yuan Seng Wu
Journal:  Acta Pharm Sin B       Date:  2019-11-14       Impact factor: 11.413

8.  Repurposing Lovastatin Cytotoxicity against the Tongue Carcinoma HSC3 Cell Line Using a Eucalyptus Oil-Based Nanoemulgel Carrier.

Authors:  Waleed Y Rizg; Khaled M Hosny; Samar S Mahmoud; Ahmed K Kammoun; Abdulmohsin J Alamoudi; Hossam H Tayeb; Haitham A Bukhary; Moutaz Y Badr; Samar S A Murshid; Eman Alfayez; Sarah A Ali; Rayan Y Mushtaq; Walaa A Abualsunun
Journal:  Gels       Date:  2022-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.